Français
ItalianoBond Bristol Myers Squibb 3.25% ( USU11009AK07 ) in USD
| Issuer | Bristol Myers Squibb | ||||||||
| Market price | 100 % ⇌ | ||||||||
| Country |  United States
|
||||||||
| ISIN code |
 USU11009AK07 ( in USD )
|
||||||||
| Interest rate | 3.25% per year ( payment 2 times a year) | ||||||||
| Maturity | 02/20/2023 - Bond has expired | ||||||||
| Minimal amount | 2 000 USD | ||||||||
| Total amount | 932 101 000 USD | ||||||||
| Cusip | U11009AK0 | ||||||||
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. Bristol Myers Squibb's USU11009AK07 bond, a USD 932,101,000 issue with a 3.25% coupon, paying semi-annually, matured on February 20, 2023, and has been redeemed at 100% of its face value. |
||||||||
| |||||||||